The Role Of hs-CRP In Predicting The Likelihood Of Coronary Heart Disease
DOI:
https://doi.org/10.32734/idjpcr.v3i1.4015Keywords:
Biomarker, hs-CRP, CHDAbstract
Coronary Heart Disease (CHD) is a disorder of the cardiovascular system, characterized by atherosclerotic lesions. Inflammation is a strong predictor for coronary heart disease. High sensitivity C-Reactive Protein (hs-CRP) is an important biomarker, synthesized in the liver, can predict the severity of CHD. If the hs-CRP level is found to be low 3 mg / L, a person has the potential for severe vascular risk. Therefore, hs-CRP can be used as a predictor of primary CHD prevention, especially if the hs-CRP level is still low.
Downloads
References
WHO, “The top 10 causes of death”, World Health Organization, 24 May 2018. [Online]. Available: https://www.who.int/news-room/fact-sheets/detail/the-top-10- causes-of-death. [Accessed: Apr 16, 2020].
P2PTM Kemenkes RI, “Hari Jantung Sedunia (HJS) Tahun 2019 : Jantung Sehat, SDM Unggul”, Direktorat Pencegahan Dan Pengendalian Penyakit Tidak Menular, 26 September 2019. [Online]. Available: http://p2ptm.kemkes.go.id. [Accessed: Apr. 16, 2020].
M. Marzilli, C.N. Merz, W.E. Boden, ”Obstructive coronary atherosclerosis and ischemic heart disease: An elusive link!”, J Am Coll Cardiol, vol.60, no.11, pp. 951- 956, Sept. 2012.
J. Wilder, M.S. Sabatine, L.S. Lilly, “Ischemic Heart Disease”, In: Pathophysiology of heart disease: a collaborative project of medical students and faculty, L.S. Lilly, 6th ed., Philadelphia: Lippincott Williams & Wilkins, 2016, 134-161. [Online]. Available:
ProQuest
G. Montalescot, U. Sechtem, A. Achenbach, et al., “ESC Guidelines on the management of stable coronary artery disease”, European Heart Journal, pp. 1-32, 2013.
T.M. Beckie, J.W. Beckstead, M.W. Groer, “The Influence of Cardiac Rehabilitation on Inflammation and Metabolic Syndrome in Women with Coronary Heart Disease”, Journal of Cardiovascular Nurse, vol. 25, no. 1, pp. 52 “ 60, 2010.
J. Kojuri, A. Karimi, N. Pourafshar, AR.Vosoughi, “Association between Serum Levels Of Hs-CRP and LDL-C with Degree of Coronary Artery Stenosis in Patients with Stable Angina Pectoris”, Iranian Red Crescent Medical Journal, vol.12, no. 4, pp. 396- 405, 2010.
J. Wang, G.J Tan, L. N. Han, Y.Y. Bai, M. He, H.B. Liu, “Novel biomarkers for cardiovascular risk prediction, Review”, Journal of Geriatric Cardiology, vol.14, pp. 135-150, 2017.
P.M. Ridker, “Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention”. Circulation. Vol. 107. pp. 363-369. 2003.
E. Marziah, A.K. Aman, A.P. Ketaren, “Correlation Between Platelet To Lymphocyte Ratio And Coronary Artery Narrowing”. Indonesian Journal Of Clinical Pathology And Medical Laboratory. Vol. 24. No.3. pp. 219-222. 2018.
A.M. Rahman, “Angina Pektoris Stabil”, In: Buku Ajar Ilmu Penyakit Dalam, A.W. Sudoyo, B. Setiyohadi, I. Alwi, M. Simadibrata, S. Seriati, Ed. 4, Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam FK-UI, 2014, 1626-8.
Z. Tan, L. Li, Y. Ma, X. Geng, “Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention”, Brazilian Journal of Cardiovascular Surgery, Vol. 34, no. 1, pp. 17-21, 2019.
H. Hasan, E. Diatami, “Angina Pectoris Stabil”, In: Nyeri Dada Dari A Sampai Z, S. Kasiman, Medan: Pustaka Bangsa, 2016, 10-40.
D.A. Morrow, W.E. Boden, “Stable Ischemic Heart Disease”, Chapter 54, In: Braunwald’s heart disease: a text book of cardiovascular medicine, Mann DL, DP. Zipes, P. Libby, RO. Bonow, and E. Braunwald, 10th ed, Philadelphia: Elsevier Saunders, 2015, 1182-1244.
D. Fairweather, E. D. Abston. M.J. Coronado, “Biomarkers of Heart Failure in Myocarditis and Dilated Cardiomyopathy”, In: Myocarditis, D. Cihakova, Croatia: Intech, 2011, 323-348. [Online]. Available: IntechOpen.
V. Nambi, A. Brautbar, CM. Ballantyne, “Novel Biomarkers and the Assessment of Cardiovascular Risk”, In: Preventive Cardiology: A Companion to Braunwald’s Heart Disease, Philadelphia: Saunders, 2011, 54 “ 63. [Online]. Available: Academia.
M. Bucova, M. Bernadic, T. Buckingham, N. Pappa, “C-Reactive Protein, Cytokines and Inflammation in Cardiovascular Disease”, Bratisl Lek Listy, vol. 109, no. 8 , pp. 333-340, 2008.
M. Sun, L. Zhang, S. Chen, X. Liu, X. Shao, H. Zou, “Association of C-Reactive Protein and Metabolic Disorder in a Chinese Population”, Int. J. Environ. Res. Public Health, vol. 12, no. 7, pp. 8228-8242, May 2015.
J. Salazar, M. S. Martínez, M.C. Castillo,V. Núñez, R. Añez, Y. Torres, A. Toledo, M. Chacín, “C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation”, Hindawi Publishing CorporationInternational Scholarly Research Notices, vol. 2014, pp. 1-11, Dec. 2014.
A. Khera, “C-Reactive Protein”, In : Biomarkers in Heart Disease, J.A. De Lemos, USA: American Heart Association National Center, 2008, pp.161 “ 180.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Indonesian Journal of Pharmaceutical and Clinical Research
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
